使用血管紧张素转换酶抑制剂治疗的患者体液流失的后果。
Consequences of fluid loss in patients treated with ACE inhibitors.
作者信息
McMurray J, Matthews D M
机构信息
Royal Infirmary, Edinburgh, UK.
出版信息
Postgrad Med J. 1987 May;63(739):385-7. doi: 10.1136/pgmj.63.739.385.
Abstract
Three patients are described in whom haemodynamic collapse and acute renal failure occurred following intercurrent gastrointestinal fluid loss during treatment with an angiotensin converting-enzyme inhibitor. The possible consequences of blockade of the formation of angiotensin II during fluid loss are discussed.
摘要
本文描述了3例患者，他们在使用血管紧张素转换酶抑制剂治疗期间因并发胃肠液丢失而发生血流动力学衰竭和急性肾衰竭。文中讨论了液体丢失期间阻断血管紧张素II形成的可能后果。
相似文献
1
Consequences of fluid loss in patients treated with ACE inhibitors.使用血管紧张素转换酶抑制剂治疗的患者体液流失的后果。
Postgrad Med J. 1987 May;63(739):385-7. doi: 10.1136/pgmj.63.739.385.
2
Acute renal failure from multiple myeloma precipitated by ACE inhibitors.血管紧张素转换酶抑制剂诱发的多发性骨髓瘤所致急性肾衰竭。
Am J Kidney Dis. 1999 Feb;33(2):E5. doi: 10.1016/s0272-6386(99)70326-4.
3
[Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor].[急性肾衰竭、肾动脉狭窄与血管紧张素转换酶（ACE）抑制剂]
Tidsskr Nor Laegeforen. 2001 Jun 10;121(15):1784-8.
4
[Fetal angiotensin converting enzyme (ACE) inhibition renal failure].
Ryoikibetsu Shokogun Shirizu. 2001(33):678-9.
5
[Changes in kidney function during treatment of heart failure patients with ACE inhibitors].[使用血管紧张素转换酶抑制剂治疗心力衰竭患者期间的肾功能变化]
Verh Dtsch Ges Inn Med. 1991;97:545-8.
6
Enalapril-induced acute kidney injury in neonates.
J Neonatal Perinatal Med. 2013;6(2):179-81. doi: 10.3233/NPM-1366012.
7
8
Angiotensin converting enzyme inhibitors may cause renal impairment in diabetes mellitus.血管紧张素转换酶抑制剂可能会导致糖尿病患者出现肾功能损害。
Scott Med J. 1988 Apr;33(2):247-8. doi: 10.1177/003693308803300209.
9
Hypotension as the etiology for angiotensin-converting enzyme (ACE) inhibitor-associated acute kidney injury in pediatric patients.低血压作为小儿患者中血管紧张素转换酶（ACE）抑制剂相关急性肾损伤的病因。
Pediatr Cardiol. 2014 Jun;35(5):767-70. doi: 10.1007/s00246-013-0850-x. Epub 2013 Dec 22.
10
Hepatotoxicity associated with angiotensin-converting enzyme inhibitors.
Ann Pharmacother. 1993 Feb;27(2):228-31. doi: 10.1177/106002809302700220.
引用本文的文献
1
Retrospective evaluation of risk factors for worsening renal function after angiotensin-converting enzyme inhibitor treatment in dogs.犬类接受血管紧张素转换酶抑制剂治疗后肾功能恶化危险因素的回顾性评估。
J Vet Intern Med. 2025 Jan-Feb;39(1):e17252. doi: 10.1111/jvim.17252. Epub 2024 Nov 20.
2
Preventing acute kidney injury in high-risk patients by temporarily discontinuing medication - an observational study in general practice.通过暂时停止用药预防高危患者的急性肾损伤 - 普通实践中的观察性研究。
BMC Nephrol. 2019 Dec 4;20(1):449. doi: 10.1186/s12882-019-1636-z.
3
Serious adverse events experienced by patients with chronic heart failure taking spironolactone.服用螺内酯的慢性心力衰竭患者经历的严重不良事件。
Heart. 2001 Apr;85(4):E8. doi: 10.1136/heart.85.4.e8.
4
Reversible impairment of renal function associated with enalapril in a diabetic patient.一名糖尿病患者中与依那普利相关的可逆性肾功能损害。
CMAJ. 1998 Nov 17;159(10):1279-81.
5
Effects of long-term treatment of captopril and enalapril on rat intestinal angiotensin converting enzyme specific activities.卡托普利和依那普利长期治疗对大鼠肠道血管紧张素转换酶比活性的影响。
Korean J Intern Med. 1994 Jul;9(2):67-71. doi: 10.3904/kjim.1994.9.2.67.
6
Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.血管紧张素转换酶（ACE）抑制剂的不良反应。最新进展。
Drug Saf. 1992 Jan-Feb;7(1):14-31. doi: 10.2165/00002018-199207010-00004.
本文引用的文献
1
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.卡托普利：关于其药理特性及在充血性心力衰竭中治疗效果的最新综述
Drugs. 1983 Jan;25(1):6-40. doi: 10.2165/00003495-198325010-00002.
2
The renin-angiotensin system in the control of systemic arterial pressure.肾素-血管紧张素系统对体循环动脉血压的调控
Drugs. 1985;30 Suppl 1:6-12. doi: 10.2165/00003495-198500301-00003.
3
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.依那普利。对其药效学和药代动力学特性以及在高血压和充血性心力衰竭中的治疗用途的综述。
Drugs. 1986 Mar;31(3):198-248. doi: 10.2165/00003495-198631030-00002.
4
Severe hypotension after first dose of enalapril in heart failure.心力衰竭患者首次服用依那普利后出现严重低血压。
Br Med J (Clin Res Ed). 1985 Nov 9;291(6505):1309-12. doi: 10.1136/bmj.291.6505.1309.
5
The renin-angiotensin system and body function.肾素-血管紧张素系统与身体功能。
Arch Intern Med. 1985 Aug;145(8):1475-9.
6
A need for new converting enzyme inhibitors?需要新型转化酶抑制剂吗？
Br Med J (Clin Res Ed). 1985 Jan 19;290(6463):180-1. doi: 10.1136/bmj.290.6463.180.
7
Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure.肾功能对重度慢性心力衰竭患者长期卡托普利治疗的血流动力学及临床反应的影响
Ann Intern Med. 1986 Feb;104(2):147-54. doi: 10.7326/0003-4819-104-2-147.
8
Control of glomerular filtration rate by renin-angiotensin system.肾素-血管紧张素系统对肾小球滤过率的调控
Am J Physiol. 1977 Nov;233(5):F366-72. doi: 10.1152/ajprenal.1977.233.5.F366.
Zotero 插件